Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
about
Oxidative stress and antioxidant activity in hypothermia and rewarming: can RONS modulate the beneficial effects of therapeutic hypothermia?Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathyThe birth and postnatal development of purinergic signallingK(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulationThe Critical Role of Bioenergetics in Donor Cardiac Allograft Preservation.Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonistsTargeting of adenosine receptors in ischemia-reperfusion injury.AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.Cardiac purinergic signalling in health and diseaseATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion ModelSignal transduction in ischemic preconditioning: the role of kinases and mitochondrial K(ATP) channels.Ischemic preconditioning: the endogenous power--a review of the literature.Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation.Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress.Adenosine and chronic ischemia of the lower limbs.Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.Role of bradykinin in preconditioning and protection of the ischaemic myocardium.Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart.Pre-conditioning with low-level laser (light) therapy: light before the storm.Adenosine: trigger and mediator of cardioprotection.Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation.Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart.The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5'-nucleotidase in rat hearts.The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.Resident cardiac mast cells and ischemia-reperfusion injury.Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.Matching coronary blood flow to myocardial oxygen consumption.Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning.Protection of the ischemic myocardium during the reperfusion: between hope and reality.Role of adenosine as adjunctive therapy in acute myocardial infarction.Ischemic preconditioning in solid organ transplantation: from experimental to clinics.Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury.Protective ischaemia in patients: preconditioning and postconditioning.Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.Preconditioning and its clinical potential.Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application.Adenosine receptors and reperfusion injury of the heart
P2860
Q27011273-CBD5E8D9-5B47-4BFB-8BC1-653625943BDBQ28211963-88C0CB6E-BFA8-4B14-B57E-C35AD7F6D83EQ28277866-E36C5296-AB7B-4D0B-B87F-C7BF2BB2629EQ28368345-3C75C42B-C091-406D-B97A-4DC290F0BD93Q30387923-5EFC9959-FA92-4F99-AF04-F828468AC040Q30425523-5364D216-7FAB-464A-8240-83F9FBDA8911Q30429069-9AA2652F-7BF8-4E8C-A212-0C0F47E1CB6FQ30433596-44B6C23E-6262-46A1-8418-55BAA4943750Q33165093-BFBE0B67-CB59-4974-B5DA-7B74D9B8C409Q33612497-8C155E8E-5595-49D7-96CC-BA29AF4F2674Q33651169-5EDA91D8-CF24-4C7F-8827-91A116FAF0C8Q33926928-BF6423AA-3943-4825-840E-F0B8F5B8D705Q34013294-66670F1A-9A92-4025-AE1D-CA2A7BBCBA47Q34025792-84B85ACD-4B40-4594-9DFD-166D2B0B0745Q34114447-08FCCB0B-0C0D-499B-BA48-222C74738CD1Q34158939-27D19B02-7D40-44FB-AD89-B7D196657CA2Q34222754-DBDFA25B-55C2-41E3-85E7-2041007EF080Q34450007-220B18DD-16EF-4BD1-9BC0-793E2BA90AB8Q34542200-07A1668E-08A5-4772-ABE6-491271DACF3AQ34633192-E7480BB0-1B53-4242-98C8-70CC2DA77C0AQ34710074-6E0D1447-8D91-4FC6-9E47-869F1BEA6DDDQ34713059-92D4E06D-8801-4234-AFDD-66D12B44E2DCQ34770600-320F3537-75AD-4111-85D6-07F2FC2DB752Q35025385-522EF473-1431-4E39-AE6C-89DF97DE1534Q35026752-71DDD6D0-716F-43AA-AABA-FC41CBBDB0A9Q35041531-55808349-953F-48A7-89CE-D2240FAA7C76Q35155262-C9B99C7F-43E2-437B-9955-0ADC73A34464Q35314768-282FC698-DA97-4FF4-931B-896B1034B9EAQ35819031-DB39B0DD-9B73-4012-9F8B-2359531D2E93Q36068993-10845FC8-C918-40D2-931A-355D0D466A5CQ36190291-3465AAC7-C0B9-463C-9F7F-215EA3DB0A1CQ36589382-135ABC73-99C6-4977-A41A-FD227F0DD68DQ36732584-A7457481-3F90-4CEF-AF2C-2E042C2B9E0AQ36872189-5D933505-6BB2-48E4-A92D-24BF7BB8F242Q37240955-97EA3DB4-C489-45D9-9303-E79BDC2131B9Q37378163-8A280D08-08C9-4FA3-ACE1-E580FE0A9907Q37420490-71A68DE7-9CBD-46E0-8A8B-C5CEB4BDEDACQ37487004-DDE41FB7-4ED5-461E-9666-8C9146B37FF3Q37528585-57A2BE38-E11F-4297-9BB3-A95DD5732F32Q37565166-50CD4BF0-C295-4B6A-AA07-8F374A570C69
P2860
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Intravenous pretreatment with ...... the heart against infarction.
@en
Intravenous pretreatment with ...... the heart against infarction.
@nl
type
label
Intravenous pretreatment with ...... the heart against infarction.
@en
Intravenous pretreatment with ...... the heart against infarction.
@nl
prefLabel
Intravenous pretreatment with ...... the heart against infarction.
@en
Intravenous pretreatment with ...... the heart against infarction.
@nl
P2093
P356
P1433
P1476
Intravenous pretreatment with ...... the heart against infarction.
@en
P2093
P304
P356
10.1161/01.CIR.85.2.659
P407
P577
1992-02-01T00:00:00Z